Business
Teva CEO Erez Vigodman bypasses Mylan's board and appeals directly to its shareholders.
Hi, what are you looking for?
Teva CEO Erez Vigodman bypasses Mylan's board and appeals directly to its shareholders.
The ruling means Teva’s flagship multiple sclerosis treatment’s patent remains valid until September 2015. The US Supreme Court has ruled in favor of...
– President Reuven Rivlin told the “Globes” 2014 Israel Business Conference that he is concerned some Israelis will not vote in the elections. –...
– Dr. Jason Furman told the “Globes” Israel Business Conference that Israel needed to diversify its bases of growth. – Dr. Jason Furman,...
– The Intel Israel President told the Globes Business Conference: If the multinational companies aren’t here, we’ll regress to the stone age. – “What...
– The Israeli content recommendation company filed confidentially, the “Wall Street Journal” reports. Outbrain Inc. has filed confidentially with the US Securities and Exchange...
– The two are exercising warrants at 43% above Thursday’s closing price. IDB Development shares are rising strongly. – The controlling shareholders in...
Digital delivery company ironSource today announced it has raised an investment of about $85 million from a syndicate of strategic and institutional investors from...
– “Reuters” reports that Taner Yildiz said Turkey is unlikely to buy Israeli gas until there is peace with Gaza. Turkish Minister of...
– – “Of course I feel good here. Jihad in our time is a personal commandment. I can’t recommend anything to you, but the...